Wall Street is positive on Chembio Diagnostics Inc (CEMI). On average, analysts give Chembio Diagnostics Inc a Buy rating. The average price target is $10, which means analysts expect the stock to climb by 250.88% over the next twelve months. That average ranking earns Chembio Diagnostics Inc an Analyst Rating of 29, which is better than 29% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating CEMI a Buy today. Find out what this means to you and get the rest of the rankings on CEMI!